Owlet, Inc.

NYSE:OWLT

Medical - Devices

Healthcare
$3.67 +9.76%

+$0.46 today

Market cap
$107.24M
Beta
1.86
P/E (TTM)
-0.4
EPS (TTM)
-$12.67
52W Low $4.19High $16.94

Volume 0.64M

Average 0.24M

OWLT Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Owlet, Inc.NYSE: OWLT

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses growth accelerates

Q1 FY2026 operating expenses of $17.73M rose 26.7% year over year, ahead of the +7.1% change in trailing-twelve-month operating expenses. Sequentially, it rose 1.2% from the prior quarter. Over 3 fiscal years it compounded at -17.0% a year.

Context

  • Operating expenses amounted to 58.5% of revenue in FY2025, down 17.8 pp from a year earlier.
  • Operating expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +26.7% holds above the trailing-twelve-month pace of +7.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$17.73M+1.2% QoQ
Last fiscal yearDec 2025
$61.79M+3.8% YoY
LTMMar 2026
$65.53M+7.1% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.7%——
1 year+3.8%——
3-year CAGR-17.0%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
61.79M USD
Year-over-year change
+3.8%
4-year CAGR
-9.2%

Operating Expenses vs competitors

How OWLT compares with its peers on the latest reported figures

  • OWLT's LTM Mar 2026 operating expenses of $65.53M is the 4th highest of the 10 companies compared; the peer median is $53.85M.
  • Its year-over-year change of +7.1% is the 6th highest of 10, against a peer median of +9.6%.
  • Operating expenses amounts to 61.2% of revenue for OWLT, versus a peer median of 200.4%.
OWLT Competitors Peer median
Operating Expenses for OWLT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AVRAnteris Technologies Global Corp.LTM Mar 2026$96.64M +13.8%+43.9%5221.2%
CRBPCorbus Pharmaceuticals Holdings, Inc.LTM Mar 2026$89.69M +109.1%+36.8%—
ANIKAnika Therapeutics, Inc.LTM Mar 2026$80.38M +22.8%+2.5%69.1%
OWLTOwlet, Inc.LTM Mar 2026$65.53M +7.1%-17.0%61.2%
MXCTMaxCyte, Inc.LTM Mar 2026$64.71M -20.8%+2.7%200.4%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$53.85M +9.6%+0.2%156.6%
LUCDLucid Diagnostics Inc.LTM Mar 2026$47.21M +5.1%-4.0%919.6%
LNSRLENSAR, Inc.LTM Mar 2026$42.7M +16.3%+8.8%74.0%
ELTXElicio Therapeutics, Inc.LTM Mar 2026$37.29M -15.8%+17.3%—
CRDFCardiff Oncology, Inc.LTM Mar 2026$36.37M -15.3%+7.1%6928.2%
Peer median (excluding OWLT) $53.85M+9.6%+7.1%200.4%

Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue75.84M69.2M54.01M78.06M105.71M
Cost of Revenue40.78M45.89M31.42M38.75M52.18M
Gross Profit35.06M23.31M22.59M39.31M53.53M
Gross Margin46.2%33.7%41.8%50.4%50.6%
Research & Development21.43M27.9M10.35M9.8M14.08M
Selling, General & Admin69.42M80.04M40.87M49.73M47.72M
Operating Expenses90.85M107.93M51.22M59.53M61.79M
Depreciation & Amortization1.13M2.67M2.21M1.38M590K
EBITDA(42.71M)(75.53M)(27.49M)(9.47M)(35.64M)
EBITDA Margin-56.3%-109.1%-50.9%-12.1%-33.7%
Operating Income(55.79M)(84.62M)(28.63M)(20.22M)(8.26M)
Operating Margin-73.6%-122.3%-53.0%-25.9%-7.8%
Interest Income00000
Interest Expense27.83M1.1M3.19M1.63M3.42M
Other Income / Expenses(15.88M)5.31M(4.26M)7.74M(31.39M)
Income Before Tax(71.67M)(79.31M)(32.89M)(12.48M)(39.65M)
Pre-Tax Margin-94.5%-114.6%-60.9%-16.0%-37.5%
Income Tax Expense31K29K10K54K28K
Net Income(71.7M)(79.34M)(32.9M)(12.54M)(39.68M)
Net Margin-94.5%-114.6%-60.9%-16.1%-37.5%
EPS (Basic)(12.47)(9.97)(4.53)(0.83)(2.24)
EPS (Diluted)(12.47)(9.97)(4.53)(0.83)(2.24)
Weighted Avg Shares7.87M7.95M8.28M15.11M562.5M
Weighted Avg Shares (Diluted)7.87M7.95M8.28M15.11M562.5M

Owlet, Inc.

NYSE:OWLT

Intrinsic Alpha fair value

Locked

Current Price

$3.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.